Header menu link for other important links
X
Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type
Preethi B,
Published in Springer Science and Business Media LLC
2016
PMID: 26329667
Volume: 45
   
Issue: 1
Pages: 35 - 44
Abstract
Nalidixic acid is an antibiotic drug used for treatment of Salmonellosis, a gastrointestinal infection. DNA gyrase subunit A (GyrA) of Salmonella typhimurium is the drug target for nalidixic acid. Resistance of GyrA to nalidixic acid, because of a point mutation in S. typhimurium, was recently reported. Substitution of Phe in place of Ser at locus 83 in GyrA of S. typhimurium has been experimentally associated with nalidixic acid resistance. Despite recent efforts, the mechanism of this resistance is not well understood. In this investigation we used computational techniques to address this shortcoming. Our results showed that contact with residue Arg 91 is certainly important for efficient binding of nalidixic acid to the target protein, and that mutation of this residue results in 180° rotation of the antibiotic in its binding pocket, around its own long axis. It is hoped these findings may enable development of new antibiotics against resistant forms of Salmonella. © 2015, European Biophysical Societies' Association.
About the journal
JournalData powered by TypesetEuropean Biophysics Journal
PublisherData powered by TypesetSpringer Science and Business Media LLC
ISSN0175-7571
Open Access0